Published in Vaccine Weekly, February 7th, 2007
The company also announced that Lance K. Gordon, PhD, has resigned as VaxGen's president, CEO and executive director. He will remain as an adviser to the company. VaxGen's board of directors unanimously appointed James P. Panek, VaxGen's executive vice president, as the company's new president and CEO and appointed him to fill the board vacancy left by Gordon.
VaxGen has retained Lazard to advise the company in exploring strategic alternatives. The process is being...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-02-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.